Literature DB >> 21357186

The number of years lived with obesity and the risk of all-cause and cause-specific mortality.

Asnawi Abdullah1, Rory Wolfe, Johannes U Stoelwinder, Maximilian de Courten, Christopher Stevenson, Helen L Walls, Anna Peeters.   

Abstract

BACKGROUND: The role of the duration of obesity as an independent risk factor for mortality has not been investigated. The aim of this study was to analyse the association between the duration of obesity and the risk of mortality.
METHODS: A total of 5036 participants (aged 28-62 years) of the Framingham Cohort Study were followed up every 2 years from 1948 for up to 48 years. The association between obesity duration and all-cause and cause-specific mortality was analysed using time-dependent Cox models adjusted for body mass index. The role of biological intermediates and chronic diseases was also explored.
RESULTS: The adjusted hazard ratio (HR) for mortality increased as the number of years lived with obesity increased. For those who were obese for 1-4.9, 5-14.9, 15-24.9 and ≥ 25 years of the study follow-up period, adjusted HRs for all-cause mortality were 1.51 [95% confidence interval (CI) 1.27-1.79], 1.94 (95% CI 1.71-2.20), 2.25 (95% CI 1.89-2.67) and 2.52 (95% CI 2.08-3.06), respectively, compared with those who were never obese. A dose-response relation between years of duration of obesity was also clear for all-cause, cardiovascular, cancer and other-cause mortality. For every additional 2 years of obesity, the HRs for all-cause, cardiovascular disease, cancer and other-cause mortality were 1.06 (95% CI 1.05-1.07), 1.07 (95% CI 1.05-1.08), 1.03 (95% CI 1.01-1.05) and 1.07 (95% CI 1.05-1.11), respectively.
CONCLUSIONS: The number of years lived with obesity is directly associated with the risk of mortality. This needs to be taken into account when estimating its burden on mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21357186     DOI: 10.1093/ije/dyr018

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  117 in total

1.  Cancers attributable to excess body weight in Canada in 2010.

Authors:  Dianne Zakaria; Amanda Shaw
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-07       Impact factor: 3.240

2.  Higher body mass index is associated with reduced posterior default mode connectivity in older adults.

Authors:  Frauke Beyer; Sharzhad Kharabian Masouleh; Julia M Huntenburg; Leonie Lampe; Tobias Luck; Steffi G Riedel-Heller; Markus Loeffler; Matthias L Schroeter; Michael Stumvoll; Arno Villringer; A Veronica Witte
Journal:  Hum Brain Mapp       Date:  2017-04-11       Impact factor: 5.038

3.  Novel oral anti-obesity agents: new perspectives with lorcaserin?

Authors:  Baptist Gallwitz
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

4.  Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial.

Authors:  P Bogdanski; M Szulinska; J Suliburska; D Pupek-Musialik; A Jablecka; H Witmanowski
Journal:  J Endocrinol Invest       Date:  2012-06-25       Impact factor: 4.256

5.  Better physical activity classification using smartphone acceleration sensor.

Authors:  Muhammad Arif; Mohsin Bilal; Ahmed Kattan; S Iqbal Ahamed
Journal:  J Med Syst       Date:  2014-07-08       Impact factor: 4.460

6.  Associations between the adherence to the Mediterranean diet and cardiorespiratory fitness with total and central obesity in preschool children: the PREFIT project.

Authors:  Idoia Labayen Goñi; Lide Arenaza; María Medrano; Natalia García; Cristina Cadenas-Sanchez; Francisco B Ortega
Journal:  Eur J Nutr       Date:  2017-11-10       Impact factor: 5.614

7.  Survival analysis with time-dependent covariates subject to missing data or measurement error: Multiple Imputation for Joint Modeling (MIJM).

Authors:  Margarita Moreno-Betancur; John B Carlin; Samuel L Brilleman; Stephanie K Tanamas; Anna Peeters; Rory Wolfe
Journal:  Biostatistics       Date:  2018-10-01       Impact factor: 5.899

8.  Phentermine and topiramate extended release (Qsymia™): first global approval.

Authors:  Fiona Cameron; Glenn Whiteside; Kate McKeage
Journal:  Drugs       Date:  2012-10-22       Impact factor: 9.546

9.  Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.

Authors:  Basilio Moreno; Ana B Crujeiras; Diego Bellido; Ignacio Sajoux; Felipe F Casanueva
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

Review 10.  Modeling obesity histories in cohort analyses of health and mortality.

Authors:  Samuel H Preston; Neil K Mehta; Andrew Stokes
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.